Загрузка...
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
We performed post-mortem studies on two patients with advanced Parkinson’s disease 8 and10 years following AAV2-neurturin (CERE120) gene therapy, the longest post-mortem trophic factor gene therapy cases reported to date. CERE120 was delivered to the putamen bilaterally in one case (10 years post-su...
Сохранить в:
| Опубликовано в: : | Brain |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089653/ https://ncbi.nlm.nih.gov/pubmed/32203581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa020 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|